Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy. Faure Bardon V, Bouazza N, Peytavin G, Le MP, et al. J Infect Dis 2025 Dec 17:jiaf619. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Faure Bardon V, Bouazza N, Peytavin G, Le MP, et al. Maternal-Fetal Letermovir Exposure in Vivo and PBPK-based: A Rationale for Congenital CMV Therapy. J Infect Dis 2025 Dec 17:jiaf619. doi: 10.1093.
PMID: 41403238